Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 50: 1289-1290, 2004; 10.1373/clinchem.2003.030072
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gingeras, T. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gingeras, T. R.
Related Collections
Right arrow Molecular Diagnostics and Genetics
Right arrow Laboratory Management
(Clinical Chemistry. 2004;50:1289-1290.)
© 2004 American Association for Clinical Chemistry, Inc.


Editorials

RNA Reference Materials for Gene Expression Studies

Point: Difficult First Steps

Thomas R. Gingeras

Affymetrix, Inc, 3380 Central Expressway, Santa Clara, CA 95051, Fax 408-481-0422, E-mail tom_gingeras@affymetrix.com

The first 20% of the full text of this article appears below.

While walking up several flights of stairs in an elevator-deprived building recently, my colleague, between some gasps of breath, turned to me and exclaimed that he had to start his New Year’s resolution and begin exercising again. At that moment this seemed to me to be a very sensible thought, given his fish-like gasping and chameleon-like color changes. However, I also recalled that my colleague had a history of serious asthma and a travel schedule that rivaled most airline pilots. I asked him how he would be managing these challenges while seeking a more healthy lifestyle. He smiled at me and said that he would deal with these issues later. "Look", he said, "at least getting some exercise is a start".

The first steps in transitioning microarray- and quantitative reverse transcription-PCR (QRT-PCR)-based human-genome-wide RNA expression profiling from the current, primarily research, applications to the more exacting medical diagnostic and drug development arenas were made recently. The NIST organized a meeting in March 2003 (1) that focused singularly on establishing the types and properties of universal RNA reference materials to be used for expression-profiling assays. A summary of the proceedings and conclusions of the meeting is reported by Cronin et al. (2) in this issue. The principal conclusion of the workshop was that two types of RNA reference materials were needed: an Assay Process Control and an Array-Specific Hybridization reference material. The reported consensus of the meeting attendees was that such RNA reference materials would provide a measure of the accuracy, dynamic range, sensitivity, specificity, and reproducibility for the multiple types of currently available RNA expression technologies (arrays and QRT-PCR). Although acknowledging that there were several major challenges . . . [Full Text of this Article]







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Association for Clinical Chemistry.